Accès partenaire

Recherche clinique

DECHSUPA N, UDOMTANAKUNCHAI C, UDOM-UTRARACHEVA A, SUTTHO D, PAZART L, HUMBERT Ph, GARRIGOS M, MANKHETKORN S. Visualization of inflammation at early stage of lung cancer in xenografted temporally immunosuppression rats by ferrioxamine magnetic resonance imaging. Int J Mol Imaging 2016, ID 8434308.

MA L, GUICHARD A, HUMBERT Ph, ZHENG S, TAN Y, YU L, QIN O, WANG X. Evaluation of the severity and triggering factors of sensitive scalp in Chinese females. J Cosmet Dermatol 2016, 15 : 219-25.

GUICHARD A, MA L, TAN Y, YUAN C, WANG H, LIHOREAU T, HUMBERT Ph, WANG X. What if scalp flora was involved in sensitive scalp onset? Int J Cosmet Sci 2016, 38 : 429-30.

PIERARD GE, PIERARD-FRANCHIMONT C, HUMBERT Ph, DELVENNE Ph. Streamlining molecular pathobiology of malignant melanoma. Clin Res Dermatol Open Access 2016 : 3 : 1-9. 

GOOROCHURN R, VIENNET C, GRANGER C, FANIAN F, VARIN-BLANK N, LE ROY C, HUMBERT Ph. Biological processes in solar lentigo: insights brought by experimental models. Exp Dermatol 2016, 25 : 174-7.

PELLETIER F, GIRARDIN M, HUMBERT Ph, PUYRAVEAU M, AUBIN F, PARRATTE B. Long-term assessment of effectiveness and quality of life of onabotulinumtoxin A injections in provoked vestibulodynia. J Eur Acad Dermatol Venereol 2016, 30 : 106-11.

FRAISON JB, SEVE P, DAUPHIN C, et al (dont HUMBERT Ph). Kawasaki disease in adults: observations in France and literature review. Autoimmun Rev 2016, 15 : 242-9.

JEUDY A, LIHOREAU T, FANIAN F, MESSIKH R, LAFFORGUE C, HUMBERT Ph. Inter-toe cracks: a cosmetic response versus excipient. Efficacy and tolerance evaluation. J Cosmet Dermatol Sci Appl 2015, 5 : 291-6.

HUMBERT Ph, GUICHARD A. The topical corticosteroid classification called into question: towards a new approach. Exp Dermatol 2015, 24 : 393-5.

YUAN C, WANG XM, GUICHARD A, LIHOREAU T, MAC-MARY S, LAMIA K, ARDIGO M, HUMBERT Ph. Comparison of reflectance confocal microscopy and standardized skin surface biopsy for three different lesions in a pityriasis folliculorum patient. Br J Dermatol2015, 172 : 1440-2.

GUICHARD A, PUZENAT E, FANIAN F, HUMBERT Ph. Le pseudomonilethrix : un artéfact plus qu’une pathologie (Lettre à la rédaction). Ann Dermatol Venereol 2015, 142 : 206-9.

ROBIN S, COURDEROT-MASUYER C, TAUZIN H, HARBON S, CHAVAGNAC-BONNEVILLE M, CADARS B, JOURDAN E, TROMPEZINSKI S, HUMBERT Ph. Use of a model of a blood-induced bruise for the evaluation of formulations on bruising. J Cosmet Dermatol Sci Appl 2015, 5 : 7-14.

GUICHARD A, HUMBERT Ph, TISSOT M, MURET P, COURDEROT-MASUYER C, VIENNET C. Effects of topical corticosteroids on cell proliferation, cell cycle progression and apoptosis: in vitro comparison on HaCaT. Int J Pharm 2015, 479 : 422-9.

PELLETIER F, GARNACHE-OTTOU F, BIICHLE S, VIVOT A, HUMBERT Ph, SAAS Ph, SEILLES E, AUBIN F. Effects of anti-TNF-alpha agents on circulating endothelial-derived and platelet-derived microparticles in psoriasis. Exp Dermatol2014, 23 : 924-5.

BIEBER T, CHOSIDOW O, BODSWORTH N et al (don’t HUMBERT Ph). Efficacy and safety of aciclovir mucoadhesive buccal tablet in immunocompetent patients with labial herpes (LIP trial): a double-blind, placebo-controlled, self-initiated trial. J Drugs Dermatol 2014, 13 : 791-8.

LARESCHE C, FOURNIER E, DUPOND AS, WORONOFF AS, DROBACHEFF-THIEBAUT C, HUMBERT Ph, AUBIN F. Kaposi’s sarcoma: a population-based cancer registry descriptive study of 57 consecutive cases diagnosed between 1977 and 2009. Int J Dermatol 2014, 53 : e549-54.

 HUMBERT Ph, FAIVRE B, VERAN Y, DEBURE C, TRUCHETET F, BECHEREL PA et al. Protease-modulating polyacrylate-based hydrogel stimulates wound bed preparation in venous ulcers: a randomized controlled trial. J Eur Acad Dermatol Venereol 2014, 28 : 1742-50.

GUICHARD A, FANIAN F, GIRARDIN P, HUMBERT Ph. Patch-test allergologique et eczéma de contact en microscopie confocale.       Ann Dermatol Venereol 2014, 141 : 805-7.

BELLANGER AP, RUNGE M, WENDLING D, HUMBERT Ph. Lumbar myositis associated with Toxocara spp. infection. Reumatol Clin 2014, 10 : 54-5.

GAMONETC, FERRAND C, COLLIOU N, MUSETTE Ph, JOLY P, GIRARDIN M, HUMBERT Ph, AUBIN F. Lack of expression of an alternative CD20 transcript variant in circulating B cells from patients with pemphigus. Exp Dermatol 2014, 23 : 66-7.

LARESCHE C, PELLETIER F, GARNACHE-OTTOU F, LIHOREAU T, BIICHLE S, MOUREY G, SAAS Ph, HUMBERT Ph, SEILLES E, AUBIN F. Increased levels of circulating microparticles are associated with increased procoagulant activity in patients with cutaneous malignant melanoma. J Invest Dermatol 2014, 134 : 176-82.

YUAN C, WANG XM, GUICHARD A, TAN YM, QIAN CY, YANG LJ, HUMBERT Ph. N-palmitoylethanolamine and N-acetylethanolamine are effective in asteatotic eczema: results of a randomized, double-blind, controlled study in 60 patients. Clin Interv Aging 2014, 9 : 1163-9.

LUGER T, SEITE S, HUMBERT Ph, KRUTMANN J, TRILLER R, DRENO B. Recommendations for adjunctive basic skin care in patients with psoriasis. Eur J Dermatol 2014, 24 : 194-200.

DESCAMPS V, AVENEL-AUDRAN M, VALEYRIE-ALLANORE I et al for the Franch study group of cutaneous adverse reactions (dont GIRARDIN P, PELLETIER F, VIGAN M). Saliva polymerase chain reaction assay for detection and follow-up of herpesvirus reactivation in patients with drug reaction with eosinophilia and systemic symptoms (DRESS). JAMA Dermatol 2013, 149 : 565-9.

DEFENDI F, CHARIGNON D, GHANNAN A et al on behalf of the National reference centre for angioedema (dont PELLETIER F, VIGAN M). Enzymatic assays for the diagnosis of Bradykinin-dependent angioedema. PLos One 2013, 8 : e70140.

POULAIN B, TREVIDIC P, CLAVE M, AHARONI C, BASPEYRAS M, BUI P, CARTIER H, CHARAVEL MH, COULON P, DAHAN S, DALLARA JM, DELONCA D, DUMAS L, ESSAYAGH E, GALATOIRE O, GEORGIEU N, GRANGIER Y, HUMBERT Ph, LE PILLOUER-PRIOST A, MOJALLAL A. Clinical equivalence of conventional  onabotulinum toxin A (900 Kda) and incobotulinum toxin A (neurotoxin free from complexing proteine, 150 Kda): 2012 multidisciplinary French consensus in aesthetics. J Drugs Dermatol 2013, 12 : 1434-46.

NOEL F, PIERARD GE, DELVENNE Ph, QUATRESOOZ P, HUMBERT Ph, PIERARD-FRANCHIMONT C. Immunohistochemical sweat gland profiles. J Cosmet Dermatol 2013, 12 : 179-86.

PIERARD GE, HUMBERT Ph, BERARDESCA E, GASPARD U, HERMANNS-LË T, PIERARD-FRANCHIMONT C. Revisiting the cutaneous impact of oral hormone replacement therapy. BioMed Res Int 2013, ID 971760.

POULAIN B, TREVIDIC P, CLAVE M, AHARONI C, BASPEYRAS M, BUI P, CARTIER H, CHARAVEL MH, COULON P, DAHAN S, DALLARA JM, DELONCA D, DUMAS L, ESSAYAGH E, GALATOIRE O, GEORGIEU N, GRANGIER Y, HUMBERT Ph, LE PILLOUER-PRIOST A, MOJALLAL A. Clinical equivalence of conventional onabotulinum toxin A (900 Kda) and incobotulinum toxin A (neurotoxin free from complexing proteine, 150 Kda): 2012 multidisciplinary French consensus in aesthetics. J Drugs Dermatol 2013, 12 : 1434-46.

BENSADOUN RJ, HUMBERT Ph, KRUTMAN J, LUGER T, TRILLER R, ROUGIER A, SEITE S, DRENO B. Daily baseline skin care in the prevention, treatment, and supportive care of skin toxicity in oncology patients: recommendations from a multinational expert panel. Cancer Manag Res 2013, 5 : 401-8.

DRENO B, BENSADOUN RJ, HUMBERT Ph, KRUTMANN J, LUGER T, TRILLER R, ROUGIER A, SEITE S. Algorithm for dermocosmetic use in the management of cutaneous side-effects associated with targeted therapy in oncology. J Eur Acad Dermatol Venereol 2013, 27 : 1071-80.

HUMBERT Ph, MIKOSINKI J, BENCHIKHI H, ALLAERT FA. Efficacy and safety of a gauze pad containing hyaluronic acid in treatment of leg ulcers of venous or mixed origin: a double-blind, randomised, controlled trial. Int Wound J 2013, 10 (2) : 159-66.

VIENNET C, GHEIT T, MURET P, AUBIN F, CABOU J, MARCHAL A, TOMMASINO M, HUMBERT Ph. Assessment of the efficacy of a new formulation for plantar wart mummification: new experimental design and human paillomavirus identification. Clin Exp Dermatol 2013, 38 : 85-8.

MAC-MARY S, MESSIKH R, JEUDY A, LIHOREAU T, SAINTHILLIER JM, GABARD B, SCHNEIDER C, AUDERSET Ph, HUMBERT Ph. Assessment of the efficacy and safety of a new treatment for head lice. ISRN Dermatol 2012, 2012 : ID 460467.

PIERARD-FRANCHIMONT C, LESUISSE M, HUMBERT Ph, DELVENNE Ph, PIERARD GE. Toxic epidermal necrolysis and antifolate drugs in cancer chemotherapy. Curr Drug Saf 2012, 7 : 357-60.

MEAUME S, TRUCHETET F, CAMBAZARD F et al, and the CHALLENGE study group (dont FAIVRE B, HUMBERT Ph). A randomized, controlled, double-blind prospective trial with a lipido-colloid technology-nano-oligosaccharide factor wound dressing in the local management of venous leg ulcers. Wound Repair Regen 2012, 20 : 500-11.

SENET P, BENETON N, DEBURE C et coll (dont HUMBERT Ph). Angiodermites nécrotiques : caractéristiques épidémiologiques et facteurs pronostiques de cicatrisation dans une cohorte prospective. Ann Dermatol Venereol 2012, 139 : 346-9.

CASTELAIN F, HUMBERT Ph. Toxic epidermal necrolysis. Curr Drug Saf 2012, 7 : 332-8.

BIVER-DALLE C, PUZENAT E, PUYRAVEAU M, DELROEUX D, BOULAHDOUR H, SHEPPARD F, PELLETIER F, HUMBERT Ph, AUBIN F. Sentinel lymph node biopsy in melanoma: our 8-year clinical experience in a single French institute (2002-2009). BMC Dermatol 2012, 12 : 21. 8 p. 

PIERARD GE, PIERARD-FRANCHIMONT C, HUMBERT Ph. Bioimpact of EGFR antagonists on the pilosebaceous follicles. Eur J Dermatol 2012, 22 : 54-7.

BIVER-DALLE C, GUICHARD A, VIGAN M, HUMBERT Ph, AUBIN F. Hypersensibilité aux dermocorticoïdes. Ann Dermatol Venereol 2012, 139 : 489-99.

GELMETTI C, BORALEVI F, SEITE S, GRIMALT R, HUMBERT Ph, LUGER T, STALDER JF, TAIEB A, TENSTEDT D, GARCIA DIAZ R, ROUGIER A. Quality of life of parents living with a child suffering from atopic dermatitis before and after a 3-month treatment with an emollient. Pediatr Dermatol 2012, 29 : 714-8.

SLEKOVEC C, FAIVRE B, HUMBERT Ph, BERTRAND X, HOCQUET D, PAZART L, TALON D. Les soins des plaies chroniques entraînent une contamination bactérienne de l’environnement. Ann Dermatol Venereol 2012, 139 : 798-802.

TRY C, MESSIKH R, ELKHYAT A, AUBIN F, HUMBERT Ph. Utilisation de l’oxybutynine à la posologie de 7,5 mg par jour dans le traitement des hyperhidroses primitives. Rev Med Liege 2012, 67 : 520-6.

BONNANS V, DROZ-BARTHOLET L, GARCIA E, LECUYER P, FAIVRE B, HUMBERT Ph. Mise en oeuvre d’un service de télédermatologie en Franche-Comté (France). Eur Res Telemed 2012, 1 : 96-103.

QUATRESOOZ P, HERMANNS-LE T, PIERARD G, HUMBERT Ph, DELVENNE Ph, PIERARD-FRANCHIMONT C. Ustekinumab in psoriasis immunopathology with emphasis on the Th17-IL23 axis: a primer. J Biomed Biotechnol 2012, 2012 : 147413.

FRANCES C, COSNES A, DUHAUT P, ZAHR N, SOUTOU B, INGEN-HOUSZ-ORO S, BESSIS D, CHEVRANT-BRETON J, CORDEL N, LIPSKER D, COSTEDOAT-CHALUMEAU N (HUMBERT Ph, contributor). Low blood concentration of hydroxychloroquine in patients with refractory cutaneous lupus erythematosus. Arch Dermatol 2012, 148 : 479-84.

PIERARD GE, HUMBERT Ph, QUATRESOOZ P. Tracking and treating malignant melanoma metastases. Dermatol Res Pract 2012 : 173491.

PENZ S, PELLETIER F, RIOU-GOTTA MO, PUZENAT E, LEVANG J, MERMET I, HUMBERT Ph, AUBIN F. Sequential therapy in plaque psoriasis using “Hit and Run” approach: infliximab followed by efalizumab. Int J Dermatol 2012, 51 : 236-7.

QUATRESOOZ P, PIERARD GE, PIERARD-FRANCHIMONT C, HUMBERT Ph, PIERARD S. Introduction à l’analyse spectrale des réseaux microvasculaires du mélanome cutané primitif. Pathol Biol 2012, 60 : 149-53. 
 
AMOS CI, WANG LE, LEE JE et al (dont HUMBERT Ph). Genome-wide association study identifies novel loci predisposing to cutaneous melanoma. Hum Mol Genet 2011, 20 (24) : 5012-23.
 
SCHOOF N, ILES MM, BISHOP DT, NEWTON-BISHOP JA, BARRETT JH, GenoMEL consortium (dont HUMBERT Ph). Pathway-based analysis of a melanoma genome-wide association study: analysis of genes related to tumour-immunosuppression. PlosOne 2011, 6 (12) : e29451 (7 p).
 
ALANTAR ALP, CABANE J, HACHULLA E, PRINC G, GINISTY D, HASSIN M, SOREL M, MAMAN L, PILAT A, MOUTHON L, Members of the working group (dont HUMBERT Ph). Recommendations for the care of oral involvement in patients with systemic sclerosis. Arthritis Care Res 2011, 63 : 1126-33.

SACCOMANI C, PENZ S, GUERRE-SCHMIDT R, PELLETIER F, PUZENAT E, RIOU-GOTTA MO, HUMBERT Ph. Experience with biologics for psoriasis in daily practice : rotational therapy is required. J Dermatolog Treat 2011, 22 (3) : 151-2. 

PIERARD GE, AUBIN F, HUMBERT Ph. Ipilimumab, a promising immunotherapy with increased overall survival in metastatic melanoma ? Dermatol Res Pract (special issue “Tracking and treating malignant melanoma”) 2011, 2012. 4 p.
 
BERTOLOTTO C, LESUEUR F, GIULIANO S, STRUB T, DE LICHY M, BILLE K, et al (dont AUBIN F et HUMBERT Ph.). A SUMOylation-defective MITF germiline mutation predisposes to melanoma and renal carcinoma. Nature 2011, 480 (7375) : 94-8.

BELLANGER AP, BAMOULID J, MILLON F, CHALOPIN JM, HUMBERT Ph. Rheumatoid purpura associated with toxocariasis: a case report. Can Fam Phys 2011, 57 : 1413-4.

PELLETIER F, GARNACHE-OTTOU F, ANGELOT F, BIICHLE S, VIDAL C, HUMBERT Ph, SAAS P, SEILLES E, AUBIN F. Increased levels of circulating endothelial-derived microparticles and small-size platelet-derived microparticles in psoriasis. J Invest Dermatol 2011, 131 : 1573-6.

BIVER-DALLE C, NGUYEN T, TOUZE A, SACCOMANI C, PENZ S, CUNAT-PEULTIER S, RIOU-GOTTA MO, HUMBERT Ph, COURSAGET P, AUBIN F. Use of interferon-alpha in two patients with Merkel cell carcinoma positive for Merkel cell polyomavirus. Acta Oncol 2011, 50 : 479-80.

PELLETIER F, PARRATTE B, PENZ S, MORENO JP, AUBIN F, HUMBERT Ph. Efficacy of high doses of botulinum toxin A for treating provoked vestibulodynia. Br J Dermatol 2011, 164 : 617-22. 

HASSAMFAR-BONAREK M, MORLAT Ph, SALMON D et al, and the Mortalité 2000 & 2005 study groups (dont HUMBERT Ph). Causes of death in HIV-infected women: persistent role of AIDS. The "Mortalité 2000 & 2005" surveys (ANRS EN19). Int J Epidemiol 2010, 39 : 135-46.
 
BELLANGER AP, HUMBERT Ph, GAVIGNET B, DESCHASEAUX AD, BARISIEN C, ROUSSEL S, MILLON L, AUBIN F, PIARROUX R. Comparative assessment of enzyme-liked immunosorbent assay and Western blot for the diagnosis of toxocariasis in patients with skin disorders. Br J Dermatol 2010, 162 : 80-2.

BIVER-DALLE C, GHEIT T, DROBACHEFF-THIEBAUT C, VIDAL C, TOMMASINO M, HUMBERT Ph, PRETET JL, MOUGIN C, AUBIN F. Detection of human papillomavirus DNA in plucked eyebrow hair from HIV-infected patients. J Invest Dermatol 2010, 130 : 2499-502.

ADHOUTE H, HAMIDOU Z, HUMBERT Ph, LYONNET C, PEUCHOT MA, REYGANE P, REYNIER C, RIVOIRE S, SIMONEAU G, TOUBEL G. Randomized study of tolerance and efficacy of a home-use intense pulsed-light (IPL) source compared to the hot-wax method. J Cosmet Dermatol 2010, 9 : 287-90. 

BONNET F, BURTY C, LEWDEN C, COSTAGLIOLA D, MAY T, BOUTELOUP V, et al. (dont HUMBERT Ph). Changes in cancer mortality among HIV-infected patients  the Mortality 2005 survey. Clin Infect Dis 2009, 48 : 633-9.

RIOU MO, FOURNIER E, DANZON A, PELLETIER F, LEVANG J, MERMET I, BLANC D, HUMBERT Ph, AUBIN F. Rare skin cancer: a population-based cancer registry descriptive study of 151 consecutive cases diagnosed between 1980 and 2004. Acta Oncol 2009, 48 (4) : 605-9. 

WENDLING D, BALBLANC JC, BRIANCON D, BROUSSE A, LOHSE A, DEPREZ P, HUMBERT Ph, AUBIN F. Onset or exacerbation of cutaneous psoriasis during TNF-alpha antagonist therapy. Joint Bone Spine 2008, 75 : 315-8.

MISERY L, THOMAS L, JULLIEN D, CAMBAZARD F, HUMBERT Ph, DUBERTRET L, DEHEN L, MACY G, BOUSSETTA S, TAIEB C. Comparative study of stress and quality of life in outpatients consulting for different dermatoses in 5 academic departments of dermatology. Eur J Dermatol 2008, 18 : 412-5.

RIOU-GOTTA MO, FOURNIER E, MERMET I, PELLETIER F, HUMBERT Ph, DANZON A, AUBIN F. Primary cutaneous lymphomas: a population-based descriptive study of 71 consecutive cases diagnosed between 1980 and 2003. Leuk Lymphoma 2008, 49 : 1537-44.

GAVIGNET B, PIARROUX R, AUBIN F, MILLON L, HUMBERT Ph. Cutaneous manifestations of human toxocariasis. J Am Acad Dermatol 2008, 59 : 1031-42.

LEWDEN C, MAY T, ROSENTHAL E, BURTY C, BONNET F, COSTAGLIOLA D, et al (dont HUMBERT Ph). Changes in causes of death among adults infected by HIV between 2000 and 2005 : the “Mortality 2000 and 2005" surveys (ANRS EN19 and Mortavic). J Acquir Immune Defic Syndr 2008, 48 (5) : 590-8.

BENNANI B, BRUCKNER T, BOCK M, FAIVRE B, REBIBOU JM, DIEPGEN T, HUMBERT Ph, AUBIN F. Low incidence of polymorphous light eruption in renal transplant recipients. Acta Derm Venereol (Stockh) 2007, 87 : 372-4.

PELLETIER F, MANZONI Ph, JACOULET P, HUMBERT Ph, AUBIN F. Pulmonary and cutaneous sarcoidosis associated with interfron therapy for melanoma. Cutis 2007, 80 : 441-5.

MAC-MARY S, SAINTHILLIER JM, COURDEROT-MASUYER C, CREIDI P, HUMBERT Ph. Could a photobiological test be a suitable method to assess the anti-oxidant effect of a nutritional supplement (Glisodin®) ? Eur J Dermatol 2007, 17 : 254-5.

MAC-MARY S, CREIDI P, MARSAUT D, COURDEROT-MASUYER C, COCHET V, GHARBI T, GUIDICELLI-ARRANZ D, TONDU F, HUMBERT Ph. Assessment of effects of an addtional dietary natural mineral water uptake on skin hydratation in healthy subjects by dynamic barrier function measurements and clinic scoring. Skin Res Technol 2006, 12 : 199-205.

KORICHI R, MAC-MARY S, ELKHYAT A, SAINTHILLIER JM, RÄNSCH P, HUMBERT Ph, VIVIANT E, GAZANO G, MAHE Ch. Development of a new sensor based on micro-electromechanical systems for objective in vivo measurement of the cutaneous temperature: application to foundations. Skin Res Technol 2006, 12 : 206-10.

GIRARDIN P, VIGAN M, HUMBERT Ph, AUBIN F. Cross-reactions in patch testing with ketoprofen, fragrance mix and cinnamic derivatives. Contact Dermatitis 2006, 55 : 126-8.

MONNIER D, VIDAL C, MARTIN L, DANZON A, PELLETIER F, PUZENAT E, ALGROS MP, BLANC D, LAURENT R, HUMBERT Ph, AUBIN F. Dermatofibrosarcoma protuberans : a population-based cancer registry descriptive study of 66 consecutive cases diagnosed between 1982 and 2002. J Eur Acad Dermatol Venereol 2006, 20 : 1237-42.

AUBIN F, VIGAN M, PUZENAT E, BLANC D, DROBACHEFF C, DEPREZ P, HUMBERT Ph, LAURENT R. Evaluation of a novel 308-nm monochromatic excimer light delivery system in dermatology: a pilot study in different chronic localized dermatoses. Br J Dermatol 2005, 152 : 99-103.

PELLETIER F, BERMONT L, PUZENAT E, BLANC D, CAIREY-REMONNAY S, MOUGIN C, LAURENT R, HUMBERT Ph, AUBIN F. Circulating vascular endothelial growth factor in cutaneous malignant melanoma. Br J Dermatol 2005, 152 : 685-9. 

CHOSIDOW O, BERNARD P, BERBIS P, HUMBERT Ph, CRICKX B, JARLIER V. Cloxacillin versus pristinamycin for superficial pyodermas: a randomized, open label, non inferiority study. Dermatology 2005, 210 (4) : 370 4.

LBOUTOUNNE H, GUILLAUME YC, MICHEL L, MAKKI S, HUMBERT Ph, MILLET J. Study and development of ancapsulated forms of 4, 5’, 8-trimethylpsoralen for topical drug delivery. Drug Dev Res 2004, 61 : 86-94.

LEVEQUE N, ROBIN S, MURET P, MAC-MARY S, MAKKI S, BERTHELOT A, KANTELIP JP, HUMBERT Ph. In vivo assessment of iron and ascorbic acid in psoriatic dermis. Acta Derm Venereol (Stockh) 2004, 84 : 2-5.

ORTONNE JP, HUMBERT Ph, NICOLAS JF, TSANKOV N, TONEV SD, JANIN A, CZERNIELEWSKI J, LAHFA M, DUBERTRET L. Intra-individual comparison of the cutaneous safety and efficacy of calcitriol 3 µg g-1 ointment and calpotriol 50 g g-1 ointment on chronic plaque psoriasis localized in facial, hairline, retroauricular or flexural areas. Br J Dermatol 2003, 148 : 326-33.

DRENO B, CHOSIDOW O, REVUZ J, MOYSE D, THE STUDY INVESTIGATOR GROUP. Lithium gluconate 8% vs. Ketoconazole 2% in the treatment of seborrhoeic dermatitis: a multicentre, randomized study. Br J Dermatol 2003, 148 : 1230-6.

BROCVIELLE H, MURET P, GOYDADIN AC, BOONE P, BROLY F, KANTELIP JP, HUMBERT Ph. N-acetyltransferase 2 acetylation polymorphism: prevalence of slow acetylators does not differ between atopic dermatitis patients and healthy subjects. Skin Pharmacol Appl Skin Physiol 2003, 16 : 386-92.

LEVEQUE N, ROBIN S, MURET P, MAC-MARY S, MAKKI S, HUMBERT Ph. High iron and low ascorbic acid concentrations in the dermis of atopic dermatitis patients. Dermatology 2003, 207 : 261-4.

HUMBERT Ph, HAFTEK M, CREIDI P, LAPIERE C, NUSGENS B, RICHARD A, SCHMITT D, ROUGIER A, ZAHOUANI H. Topical ascorbic acid on photoaged skin: clinical, topographical and ultrastructural evaluation  double-blind study versus placebo. Exp Dermatol 2003, 12 : 237-44.

DRENO B, MOYSE D, ALIREZAI M, AMBLARD P, AUFFRET N, BEYLOT C, BODOCK I, CHIVOT M, DANIEL F, HUMBERT Ph, MEYNADIER J, POLI F. Multicenter randomized comparative double blind controlled clinical trial of the safety and efficacy of zinc gluconate versus minocycline hydrochloride in the treatment of inflammatory acne vulgaris. Dermatology 2001, 203 : 135-40.

AUBIN F, CAHN JY, FERRAND C, ANGONIN R, HUMBERT Ph, TIBERGHIEN P. Extensive vitiligo after ganciclovir treatment of GvHD in a patient who had received donor T cells expressing herpes simplex virus thymidine kinase. Lancet 2000, 355 : 626-7.

AUBIN F, CHTOUROU M, TEYSSIER JR, LAUBRIET A, MOUGIN CH, BLANC D, HUMBERT Ph. The detection of tyrosinase mRNA in the peripheral blood of stage I melanoma patients is not of clinical relevance in predicting metastasis risk and survival. Melanoma Res 2000, 10 : 113-8.

ALIREZAI M, VIE K, HUMBERT Ph, VALENSI P, CAMBON L, DUPUY P. A low-salt medical water reduces irritancy of retinoic acid in facial acne. Eur J Dermatol 2000, 10 : 370-2.

HUMBERT Ph, NIEZBORALA M, SALEMBIER R, AUBIN F, PIARROUX R, BUCHET S, BARALE Th. Skin manifestations associated with toxocariasis : a case-control study. Dermatology 2000, 201: 230-4.
 
 
réalisation amenothès conception